Anil Chekuri, PhD


Anil Chekuri, PhD, has been focused on understanding the molecular bases of Inherited Retinal Degenerations (IRDs) and Age-related Macular Degeneration (AMD). He aims to investigate key molecular pathways underlying several forms of retinal dystrophies and development of therapeutic targets to rescue retinal function. His research also focuses on the development of novel Adeno Associated Viral (AAV) vectors with improved retinal tropism and efficacy for therapeutic delivery suitable for translational studies. Dr. Chekuri is currently working to develop gene therapy for various forms of retinal disorders.

Vandenberghe Lab Team

  • Luk H. Vandenberghe, PhD

    Director (on leave)

  • Nerea Zabaleta, PhD


  • Reynette Estelien

    Lead Research Lab Tech

  • Jiten Doshi, PhD

    Postdoctoral Research Fellow

  • Huachun Liu, PhD

    Postdoctoral Research Fellow

  • Paige Osborn

    Program Coordinator

  • Matt Chagnon

    Research Lab Tech I

  • Uday Kumar Chekkilla, PhD

    Postdoctoral Research Fellow

  • Yu Ning, PhD

    Postdoctoral Research Fellow

© 2018 Grousbeck Gene Therapy Center

20 Staniford Street, Boston, MA 02114